Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362480933> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W4362480933 abstract "<div>Abstract<p>Barrett's esophagus (BE), a recognized risk factor for esophageal adenocarcinoma (EAC), is routinely managed with proton pump inhibitors (PPIs) when symptomatic. Several lines of evidence suggest that PPIs may prevent malignant transformation. Chronic use of other common drugs, namely, statins nonsteroidal anti-inflammatory drugs (NSAIDs) and metformin, may also interfere with BE carcinogenesis, but confirmatory evidence is lacking. We identified 1,943 EAC cases and 19,430 controls (matched 10:1) between 2007 and 2013 that met our specified inclusion criteria in the SEER–Medicare database. Conditional logistic regression was used to generate odds ratios (OR) and 95% confidence intervals (95% CI). Wald χ<sup>2</sup> tests were used to assess significance of covariates. Compared with controls, EAC cases had a higher prevalence of BE (26.2%). Use of PPIs, NSAIDs, statins, or metformin reduced the odds of EAC (PPIs: 0.10; 95% CI, 0.09–0.12; NSAIDs: 0.62; 95% CI, 0.51–0.74; statins: 0.15; 95% CI, 0.13–0.17; metformin: 0.76; 95% CI, 0.62–0.93). When stratified by BE, these associations persisted, though no association was found between NSAID use and EAC risk for participants with BE. Dual use of PPIs with NSAIDs or statins, and NSAID, statin, or metformin use alone also showed significant EAC risk reduction among all participants and those without BE. Use of PPIs alone and with NSAIDs, statins, or metformin was associated with reduced risk of EAC; however, a history of BE may diminish drug efficacy. These results indicate that common pharmacologic agents alone or in combination may decrease EAC development.</p><p><b>Prevention Relevance:</b> The use of common drugs, such as proton pump inhibitors, statins, non-steroidal anti-inflammatory drugs, or metformin, may reduce one's risk of developing esophageal adenocarcinoma. These results suggest that repurposing agents often used for common chronic conditions may be a new strategy for cancer prevention efforts.</p></div>" @default.
- W4362480933 created "2023-04-05" @default.
- W4362480933 creator A5004061795 @default.
- W4362480933 creator A5008765045 @default.
- W4362480933 creator A5020471320 @default.
- W4362480933 creator A5067186924 @default.
- W4362480933 date "2023-04-03" @default.
- W4362480933 modified "2023-09-24" @default.
- W4362480933 title "Data from Association of Common Use Pharmaceuticals in Reducing Risk of Esophageal Adenocarcinoma: A SEER–Medicare Analysis" @default.
- W4362480933 doi "https://doi.org/10.1158/1940-6207.c.6546997.v1" @default.
- W4362480933 hasPublicationYear "2023" @default.
- W4362480933 type Work @default.
- W4362480933 citedByCount "0" @default.
- W4362480933 crossrefType "posted-content" @default.
- W4362480933 hasAuthorship W4362480933A5004061795 @default.
- W4362480933 hasAuthorship W4362480933A5008765045 @default.
- W4362480933 hasAuthorship W4362480933A5020471320 @default.
- W4362480933 hasAuthorship W4362480933A5067186924 @default.
- W4362480933 hasBestOaLocation W43624809332 @default.
- W4362480933 hasConcept C121608353 @default.
- W4362480933 hasConcept C126322002 @default.
- W4362480933 hasConcept C143998085 @default.
- W4362480933 hasConcept C156957248 @default.
- W4362480933 hasConcept C2776839432 @default.
- W4362480933 hasConcept C2779306644 @default.
- W4362480933 hasConcept C2779742542 @default.
- W4362480933 hasConcept C2780323712 @default.
- W4362480933 hasConcept C44249647 @default.
- W4362480933 hasConcept C71924100 @default.
- W4362480933 hasConcept C90924648 @default.
- W4362480933 hasConceptScore W4362480933C121608353 @default.
- W4362480933 hasConceptScore W4362480933C126322002 @default.
- W4362480933 hasConceptScore W4362480933C143998085 @default.
- W4362480933 hasConceptScore W4362480933C156957248 @default.
- W4362480933 hasConceptScore W4362480933C2776839432 @default.
- W4362480933 hasConceptScore W4362480933C2779306644 @default.
- W4362480933 hasConceptScore W4362480933C2779742542 @default.
- W4362480933 hasConceptScore W4362480933C2780323712 @default.
- W4362480933 hasConceptScore W4362480933C44249647 @default.
- W4362480933 hasConceptScore W4362480933C71924100 @default.
- W4362480933 hasConceptScore W4362480933C90924648 @default.
- W4362480933 hasLocation W43624809331 @default.
- W4362480933 hasLocation W43624809332 @default.
- W4362480933 hasOpenAccess W4362480933 @default.
- W4362480933 hasPrimaryLocation W43624809331 @default.
- W4362480933 hasRelatedWork W1545000863 @default.
- W4362480933 hasRelatedWork W1971875340 @default.
- W4362480933 hasRelatedWork W1973855633 @default.
- W4362480933 hasRelatedWork W1984235851 @default.
- W4362480933 hasRelatedWork W1998904218 @default.
- W4362480933 hasRelatedWork W2120855083 @default.
- W4362480933 hasRelatedWork W2131983647 @default.
- W4362480933 hasRelatedWork W2317313649 @default.
- W4362480933 hasRelatedWork W2809716484 @default.
- W4362480933 hasRelatedWork W4292182750 @default.
- W4362480933 isParatext "false" @default.
- W4362480933 isRetracted "false" @default.
- W4362480933 workType "article" @default.